Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.

Fu J, Lv H, Guan H, Ma X, Ji M, He N, Shi B, Hou P.

BMC Cancer. 2013 Oct 8;13:462. doi: 10.1186/1471-2407-13-462.

2.

ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.

Qiang W, Zhao Y, Yang Q, Liu W, Guan H, Lv S, Ji M, Shi B, Hou P.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1163-72. doi: 10.1210/jc.2013-3729. Epub 2014 Mar 31.

PMID:
24684457
3.
4.

Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.

Ferrario C, Lavagni P, Gariboldi M, Miranda C, Losa M, Cleris L, Formelli F, Pilotti S, Pierotti MA, Greco A.

Lab Invest. 2008 May;88(5):474-81. doi: 10.1038/labinvest.2008.17. Epub 2008 Mar 10.

5.

MT1G hypermethylation is associated with higher tumor stage in prostate cancer.

Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1274-8.

6.

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Ma Y, Qin H, Cui Y.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):958-63. doi: 10.1016/j.bbrc.2013.11.010. Epub 2013 Nov 9.

PMID:
24220341
7.

Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue.

Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM, Peng ZH.

Biochim Biophys Acta. 2012 Jun;1822(6):918-26. doi: 10.1016/j.bbadis.2012.02.021. Epub 2012 Mar 9.

8.

LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.

Liu WB, Jiang X, Han F, Li YH, Chen HQ, Liu Y, Cao J, Liu JY.

Cell Death Dis. 2013 Oct 24;4:e882. doi: 10.1038/cddis.2013.366.

9.

Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.

Li JY, Han C, Zheng LL, Guo MZ.

Chin Med J (Engl). 2012 Oct;125(19):3526-31.

10.

Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Ma S, Bao JY, Kwan PS, Chan YP, Tong CM, Fu L, Zhang N, Tong AH, Qin YR, Tsao SW, Chan KW, Lok S, Guan XY.

Gastroenterology. 2012 Sep;143(3):675-86.e1-12. doi: 10.1053/j.gastro.2012.06.007. Epub 2012 Jun 13.

PMID:
22705009
11.

ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.

Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z, Tao Q, Ng EK, Fang J, Sung JJ, Yu J.

Oncogene. 2013 Jul 11;32(28):3319-28. doi: 10.1038/onc.2012.359. Epub 2012 Aug 20.

PMID:
22907434
12.

Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.

Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ.

Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.

PMID:
20802524
13.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

14.

Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway.

Wang S, Kang W, Go MY, Tong JH, Li L, Zhang N, Tao Q, Li X, To KF, Sung JJ, Yu J.

Mol Med. 2012 Dec 20;18:1402-11. doi: 10.2119/molmed.2012.00243.

15.

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

Zhang J, Wang C, Chen M, Cao J, Zhong Y, Chen L, Shen HM, Xia D.

BMC Cancer. 2013 Dec 14;13:601. doi: 10.1186/1471-2407-13-601.

16.

DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma.

Yin DT, Wu W, Li M, Wang QE, Li H, Wang Y, Tang Y, Xing M.

Endocr Relat Cancer. 2013 Jun 27;20(4):507-14. doi: 10.1530/ERC-13-0053. Print 2013 Aug.

17.

[Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].

Lu XX, Ge MH, Ling ZQ, Hu SS, Xu J, Zheng CM, Tan Z, Chen C.

Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):833-6. Chinese.

PMID:
24447481
18.

Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.

Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.

Int J Oncol. 2009 Sep;35(3):477-83.

PMID:
19639168
19.

Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.

Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.

Int J Cancer. 2014 Mar 15;134(6):1311-22. doi: 10.1002/ijc.28472. Epub 2013 Nov 11.

20.

Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.

Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MY, Shen B, Cheng AS, Ying J, Tao Q, Sung JJ, Kung HF, Yu J.

Oncogene. 2012 Jul 19;31(29):3419-30. doi: 10.1038/onc.2011.511. Epub 2011 Nov 21. Erratum in: Oncogene. 2012 Jul 19;31(29):3482.

PMID:
22105368
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk